Quantum-Si Incorporated (NASDAQ:QSI) Stock Now Rated “Hold” by Wall Street Analysts

Quantum-Si Incorporated (NASDAQ:QSI – Get Free Report) has been assigned an average recommendation of “Hold” from the five analysts that are currently covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and three have assigned a buy recommendation to the company. The average 1 year price target among brokerages that have updated their coverage on the stock in the last year is $2.50.

QSI has been the subject of several recent analyst reports. HC Wainwright restated a “buy” rating on shares of Quantum-Si in a research note on Thursday, November 12th. UBS Group reaffirmed a “buy” rating on shares of Quantum-Si in a research report on Thursday, November 12th. Alliance Global Partners reiterated a “buy” rating on shares of Quantum-Si in a research note on Friday, August 14th. Wall Street Zen raised Quantum-Si from a “sell” rating to a “hold” rating in a report on Tuesday, October 27th. Finally, Weiss Ratings upgraded Quantum-Si from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Thursday, September 24th.

View Our Latest Research Report on Quantum-Si

Quantum-Si Trading Up 5.9%

NASDAQ QSI opened at $1.07 on Thursday. The stock has a market cap of $235.12 million, a P/E ratio of -2.74 and a beta of 3.26. The company’s fifty day simple moving average is $1.16 and its 200-day simple moving average is $0.96. Quantum-Si has a 52 week low of $0.69 and a 52 week high of $1.81.

Quantum-Si (NASDAQ:QSI – Get Free Report) last released its quarterly earnings results on Thursday, November 5th. The company reported ($0.10) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.12) by $0.02. Quantum-Si had a negative net margin of 6,729.80% and a negative return on equity of 44.72%. The business had revenue of $0.21 million during the quarter, compared to analyst estimates of $0.27 million. On average, research analysts expect that Quantum-Si will post -0.42 EPS for the current fiscal year.

Hedge Funds Weigh In On Quantum-Si

A number of institutional investors have recently made changes to their positions in QSI. Knollwood Investment Advisory LLC bought a new stake in shares of Quantum-Si in the third quarter worth $321,000. Goldman Sachs Group Inc. acquired a new stake in Quantum-Si in the third quarter valued at $274,000. Empowered Funds LLC acquired a new stake in Quantum-Si in the third quarter valued at $210,000. Verdence Capital Advisors LLC bought a new position in Quantum-Si during the 3rd quarter valued at $143,000. Finally, Renaissance Technologies LLC bought a new position in Quantum-Si during the 1st quarter valued at $91,000. 39.90% of the stock is owned by institutional investors and hedge funds.

About Quantum-Si

(Get Free Report)

Quantum-Si is a life sciences technology company developing tools for protein sequencing and proteomics research. Its platform uses semiconductor technology and single-molecule detection to analyze proteins, with the aim of making protein-level information more accessible to researchers. The company’s offerings include the Platinum benchtop instrument, along with consumables, reagents and software used to prepare, run and analyze samples. Quantum-Si’s products are designed for research applications in areas such as drug discovery and biological research.

See Also

Analyst Recommendations for Quantum-Si (NASDAQ:QSI)

Receive News & Ratings for Quantum-Si Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quantum-Si and related companies with MarketBeat.com's FREE daily email newsletter.